Nebulizers Market By Type (Mesh, Jet, Ultrasonic), Usage (Reusable, Disposable), Portability (Tabletop, Portable), End User (Hospitals and Clinics, Homecare, Others) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast to 2032

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. Impact of Covid-19 on the Global Nebulizers Market

5.3.1. Impact on Supply Chain

5.3.2. Impact on Pricing

5.3.3. Impact in Major Regions (Americas, Europe, Asia-Pacific, and Middle East & Africa)

6. GLOBAL NEBULIZERS MARKET, BY TYPE

6.1. Overview

6.2. Mesh

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.2.1. Active

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.2.2. Passive

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.3. Jet

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.4. Ultrasonic

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

7. GLOBAL NEBULIZERS MARKET, BY USAGE

7.1. Overview

7.2. Reusable

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

7.3. Disposable

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

8. GLOBAL NEBULIZERS MARKET, BY PORTABILITY

8.1. Overview

8.2. Tabletop

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

8.3. Portable

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

9. GLOBAL NEBULIZERS MARKET, BY END USER

9.1. Overview

9.2. Hospitals and Clinics

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

9.3. Homecare

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

9.4. Others

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

10. GLOBAL NEBULIZERS MARKET, BY REGION

10.1. Overview

10.2. Americas

10.2.1. North America

10.2.1.1. US

10.2.1.2. Canada

10.2.2. Latin America

10.3. Europe

10.3.1. Western Europe

10.3.1.1. Germany

10.3.1.2. France

10.3.1.3. Italy

10.3.1.4. Spain

10.3.1.5. UK

10.3.1.6. Rest of Western Europe

10.3.2. Eastern Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Middle East & Africa

10.5.1. Middle East

10.5.2. Africa

11. COMPANY LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategy in the Global Nebulizers Market

11.5. Competitive Benchmarking

11.6. Leading Players in terms of Number of Developments in the Global Nebulizers Market

11.7. Key developments and Growth Strategies

11.7.1. New Product Launch/Service Deployment

11.7.2. Merger & acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix & Market Ratio

11.8.1. Sales & Operating Income 2019

11.8.2. Major Players R&D Expenditure 2019

11.9. Major Players Capital Market Ratio

12. COMPANY PROFILES

12.1. OMRON Healthcare

12.1.1. Company Overview

12.1.2. Product Overview

12.1.3. Financial Overview

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Koninklijke Philips N.V.

12.2.1. Company Overview

12.2.2. Product Overview

12.2.3. Financial Overview

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. PARI

12.3.1. Company Overview

12.3.2. Product Overview

12.3.3. Financial Overview

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. Vectura Group plc

12.4.1. Company Overview

12.4.2. Product Overview

12.4.3. Financial Overview

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. Rossmax International Ltd

12.5.1. Company Overview

12.5.2. Product Overview

12.5.3. Financial Overview

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. Briggs Healthcare

12.6.1. Company Overview

12.6.2. Product Overview

12.6.3. Financial Overview

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. GF Health Products, Inc.

12.7.1. Company Overview

12.7.2. Product Overview

12.7.3. Financial Overview

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. Beurer GmBH

12.8.1. Company Overview

12.8.2. Product Overview

12.8.3. Financial Overview

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.8.6. Key Strategies

12.9. Agilent Technologies, Inc.

12.9.1. Company Overview

12.9.2. Product Overview

12.9.3. Financial Overview

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.9.6. Key Strategies

12.10. Drive DeVilbiss Healthcare

12.10.1. Company Overview

12.10.2. Product Overview

12.10.3. Financial Overview

12.10.4. Key Developments

12.10.5. SWOT Analysis

12.10.6. Key Strategies

12.11. Invacare Corporation

12.11.1. Company Overview

12.11.2. Product Overview

12.11.3. Financial Overview

12.11.4. Key Developments

12.11.5. SWOT Analysis

12.11.6. Key Strategies

12.12. B. Braun Melsungen AG

12.12.1. Company Overview

12.12.2. Product Overview

12.12.3. Financial Overview

12.12.4. Key Developments

12.12.5. SWOT Analysis

12.12.6. Key Strategies

12.13. Others

13. APPENDIX

13.1. References

13.2. Related Reports

NOTE:

This table of content is tentative and subject to change as the research progresses.

• In section 12, major 10 companies will be profiled. Each company will be profiled based on the Market Overview, Financials, Product Portfolio, Business Strategies, and Recent Development parameters.

• Please note: The financial details of the company cannot be provided if the information is not available in the public domain and or from reliable sources. 

LIST OF TABLES

TABLE 1 GLOBAL NEBULIZERS MARKET SYNOPSIS, 2022–2030

TABLE 2 GLOBAL NEBULIZERS MARKET ESTIMATES & FORECAST, 2022–2030 (USD MILLION)

TABLE 3 GLOBAL NEBULIZERS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 4 GLOBAL NEBULIZERS MARKET, BY USAGE, 2022–2030 (USD MILLION)

TABLE 5 GLOBAL NEBULIZERS MARKET, BY PORTABILITY, 2022–2030 (USD MILLION)

TABLE 6 GLOBAL NEBULIZERS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 7 GLOBAL NEBULIZERS MARKET, BY REGION, 2022–2030 (USD MILLION)

TABLE 8 NORTH AMERICA: NEBULIZERS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 9 NORTH AMERICA: NEBULIZERS MARKET, BY USAGE, 2022–2030 (USD MILLION)

TABLE 10 NORTH AMERICA: NEBULIZERS MARKET, BY PORTABILITY, 2022–2030 (USD MILLION)

TABLE 11 NORTH AMERICA: NEBULIZERS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 12 US: NEBULIZERS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 13 US: NEBULIZERS MARKET, BY USAGE, 2022–2030 (USD MILLION)

TABLE 14 US: NEBULIZERS MARKET, BY PORTABILITY, 2022–2030 (USD MILLION)

TABLE 15 US: NEBULIZERS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 16 CANADA: NEBULIZERS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 17 CANADA: NEBULIZERS MARKET, BY USAGE, 2022–2030 (USD MILLION)

TABLE 18 CANADA: NEBULIZERS MARKET, BY PORTABILITY, 2022–2030 (USD MILLION)

TABLE 19 CANADA: NEBULIZERS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 20 LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 21 LATIN AMERICA: NEBULIZERS MARKET, BY USAGE, 2022–2030 (USD MILLION)

TABLE 22 LATIN AMERICA: NEBULIZERS MARKET, BY PORTABILITY, 2022–2030 (USD MILLION)

TABLE 23 LATIN AMERICA: NEBULIZERS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 24 EUROPE: NEBULIZERS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 25 EUROPE: NEBULIZERS MARKET, BY USAGE, 2022–2030 (USD MILLION)

TABLE 26 EUROPE: NEBULIZERS MARKET, BY PORTABILITY, 2022–2030 (USD MILLION)

TABLE 27 EUROPE: NEBULIZERS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 28 WESTERN EUROPE: NEBULIZERS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 29 WESTERN EUROPE: NEBULIZERS MARKET, BY USAGE, 2022–2030 (USD MILLION)

TABLE 30 WESTERN EUROPE: NEBULIZERS MARKET, BY PORTABILITY, 2022–2030 (USD MILLION)

TABLE 31 WESTERN EUROPE: NEBULIZERS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 32 EASTERN EUROPE: NEBULIZERS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 33 EASTERN EUROPE: NEBULIZERS MARKET, BY USAGE, 2022–2030 (USD MILLION)

TABLE 34 EASTERN EUROPE: NEBULIZERS MARKET, BY PORTABILITY, 2022–2030 (USD MILLION)

TABLE 35 EASTERN EUROPE: NEBULIZERS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 36 ASIA-PACIFIC: NEBULIZERS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 37 ASIA-PACIFIC: NEBULIZERS MARKET, BY USAGE, 2022–2030 (USD MILLION)

TABLE 38 ASIA-PACIFIC: NEBULIZERS MARKET, BY PORTABILITY, 2022–2030 (USD MILLION)

TABLE 39 ASIA-PACIFIC: NEBULIZERS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA: NEBULIZERS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA: NEBULIZERS MARKET, BY USAGE, 2022–2030 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA: NEBULIZERS MARKET, BY PORTABILITY, 2022–2030 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA: NEBULIZERS MARKET, BY END USER, 2022–2030 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL NEBULIZERS MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL NEBULIZERS MARKET

FIGURE 4 GLOBAL NEBULIZERS MARKET SHARE, BY TYPE, 2019 (%)

FIGURE 5 GLOBAL NEBULIZERS MARKET SHARE, BY USAGE, 2019 (%)

FIGURE 6 GLOBAL NEBULIZERS MARKET SHARE, BY PORTABILITY, 2019 (%)

FIGURE 7 GLOBAL NEBULIZERS MARKET SHARE, BY END USER, 2019 (%)

FIGURE 8 GLOBAL NEBULIZERS MARKET SHARE, BY REGION, 2019 (%)

FIGURE 7 AMERICAS: NEBULIZERS MARKET SHARE BY REGION, 2019 (%)

FIGURE 9 NORTH AMERICA: NEBULIZERS MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 10 EUROPE: NEBULIZERS MARKET SHARE, BY REGION, 2019 (%)

FIGURE 11 WESTERN EUROPE: NEBULIZERS MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 12 ASIA-PACIFIC: NEBULIZERS MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 13 MIDDLE EAST & AFRICA: NEBULIZERS MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 14 GLOBAL NEBULIZERS MARKET: COMPANY SHARE ANALYSIS, 2019 (%)

FIGURE 15 OMRON HEALTHCARE.: KEY FINANCIALS

FIGURE 16 OMRON HEALTHCARE: SEGMENTAL REVENUE

FIGURE 17 OMRON HEALTHCARE: REGIONAL REVENUE

FIGURE 18 KONINKLIJKE PHILIPS N.V.: KEY FINANCIALS

FIGURE 19 KONINKLIJKE PHILIPS N.V.: SEGMENTAL REVENUE

FIGURE 20 KONINKLIJKE PHILIPS N.V.: REGIONAL REVENUE

FIGURE 21 PARI: KEY FINANCIALS

FIGURE 22 PARI: SEGMENTAL REVENUE

FIGURE 23 PARI: REGIONAL REVENUE

FIGURE 24 VECTURA GROUP PLC: KEY FINANCIALS

FIGURE 25 VECTURA GROUP PLC: SEGMENTAL REVENUE

FIGURE 26 VECTURA GROUP PLC: REGIONAL REVENUE

FIGURE 27 ROSSMAX INTERNATIONAL LTD: KEY FINANCIALS

FIGURE 28 ROSSMAX INTERNATIONAL LTD: SEGMENTAL REVENUE

FIGURE 29 ROSSMAX INTERNATIONAL LTD: REGIONAL REVENUE

FIGURE 30 BRIGGS HEALTHCARE: KEY FINANCIALS

FIGURE 31 BRIGGS HEALTHCARE: SEGMENTAL REVENUE

FIGURE 32 BRIGGS HEALTHCARE: REGIONAL REVENUE

FIGURE 33 GF HEALTH PRODUCTS, INC.: KEY FINANCIALS

FIGURE 34 GF HEALTH PRODUCTS, INC.: SEGMENTAL REVENUE

FIGURE 35 GF HEALTH PRODUCTS, INC.: REGIONAL REVENUE

FIGURE 36 BEURER GMBH: KEY FINANCIALS

FIGURE 37 BEURER GMBH: SEGMENTAL REVENUE

FIGURE 38 BEURER GMBH: REGIONAL REVENUE

FIGURE 39 AGILENT TECHNOLOGIES, INC.: KEY FINANCIALS

FIGURE 40 AGILENT TECHNOLOGIES, INC.: SEGMENTAL REVENUE

FIGURE 41 AGILENT TECHNOLOGIES, INC.: REGIONAL REVENUE

FIGURE 42 DRIVE DEVILBISS HEALTHCARE: KEY FINANCIALS

FIGURE 43 DRIVE DEVILBISS HEALTHCARE: SEGMENTAL REVENUE

FIGURE 44 DRIVE DEVILBISS HEALTHCARE: REGIONAL REVENUE

FIGURE 45 INVACARE CORPORATION: KEY FINANCIALS

FIGURE 46 INVACARE CORPORATION: SEGMENTAL REVENUE

FIGURE 47 INVACARE CORPORATION: REGIONAL REVENUE

FIGURE 48 B. BRAUN MELSUNGEN AG: KEY FINANCIALS

FIGURE 49 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE

FIGURE 50 B. BRAUN MELSUNGEN AG: REGIONAL REVENUE